J&J Medical Connect
DARZALEX®

(daratumumab)

+ Save link
J&J Medical Connect

Connect with us

Connect with us

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

DARZALEX® (daratumumab)

Medical Information

DARZALEX - Latex Content

Last Updated: 10/12/2025

SUMMARY  

  • DARZALEX is supplied as a colorless to yellow preservative-free liquid concentrate for intravenous infusion after dilution and is supplied in single-dose vials.1
  • The excipients and immediate container do not contain latex/natural rubber. However, it cannot be guaranteed that the materials do not come in contact with latex during the manufacturing or packaging process (e.g., latex gloves).2

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File databases (and/or other resources, including internal/external databases) was conducted on 09 October 2025.

 

References

Show
1 Data on File. Daratumumab IV Company Core Data Sheet (CCDS). Janssen Research & Development, LLC. EDMS-ERI-78724630; 2025.  
2 Data on File. Technical Document Patient Safety and Compliance Information for Darzalex. Janssen Research & Development, LLC. TV-TEC-161006; 2024.